허혈성 뇌졸중 환자에서 클로피도그렐과 티클로피딘의 혈소판기능검사

키워드

참고문헌 (34)

1. Quinn MJ, "Ticlopidine and clopidogrel", Circulation, 100, pp.1667~1672 (1999)
2. CAPRIE Steering Committee, "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk ischemic events (CAPRIE)", Lancet, 348, pp.1329~1339 (1996)
3. Hass WK, "A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group", N Engl J Med, 321, pp.501~507 (1989)
4. Gent M, "The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke", Lancet, 1, pp.1215~1220 (1989)
5. Lau WC, "Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4", Pharm Res, 23, pp.2691~2708 (2006)
6. Gurbel PA, "Clopidogrel resistance", Thromb Res, 120, pp.311~321 (2007)
7. 전성만, "급성기 뇌경색에서의 Clopidogrel의 저항성", 대한신경과학회지, 24(4), pp.319~323 (2006), 대한신경과학회
8. 천상명, "항혈소판제제에 따른 뇌경색 환잔의 혈소판 응집력의 차이", 대한신경과학회지, 22(1), pp.11~15 (2004), 대한신경과학회
9. Pongrácz E, "Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke", Clin Hemorheol Microcirc, 30, pp.237~242 (2004)
10. 김재국, "허혈성 뇌졸중 환자에서 신속혈소판기능 검사를 이용한 클로피도그렐의 혈소판 응집 억제 반응 측정", 대한신경과학회지, 26(4), pp.301~307 (2008), 대한신경과학회
11. Barnett HJ, "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators", N Engl J Med, 339, pp.1415~1425 (1998)
12. U-King-Im JM, "Measuring carotid stenosis on contrastenhanced magnetic resonance angiography: diagnostic performance and reproducibility of 3 different methods", Stroke, 35, pp.2083~2088 (2004)
13. Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
14. Malinin A, "Validation of a VerifyNowⓇ-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel", Methods Find Exp Clin Pharmacol, 28, pp.315~322 (2006)
15. Angiolillo DJ, "High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability", Eur Heart J, 25, pp.1903~1910 (2004)
16. Michelson AD, "Platelet function testing in cardiovascular diseases", Circulation, 110, pp.489~493 (2004)
17. Martin A, "Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12Ⓡ rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study", Thromb Res, 119, pp.277~284 (2007)
18. Paniccia R, "Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients", J Thromb Haemost, 5, pp.1839~1847 (2007)
19. von Beckerath N, "Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness", Thromb Haemost, 95, pp.910~911 (2006)
20. Järemo P, "Individual variations of platelet inhibition after loading doses of clopidogrel", J Intern Med, 252, pp.233~238 (2002)
21. Serebruany VL, "Variability in platelet responsiveness to clopidogrel among 544 individuals", J Am Coll Cardiol, 45, pp.246~251 (2005)
22. Price MJ, "Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation", Eur Heart J, 29, pp.992~1000 (2008)
23. Breet NJ, "Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation", JAMA, 303, pp.754~762 (2010)
24. 이경훈, "The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P2Y12 Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation", Korean Circulation Journal, 39(12), pp.512~518 (2009), 대한심장학회
25. Campo G, "Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study", J Am Coll Cardiol, 50, pp.1132~1137 (2007)
26. Mega JL, "Cytochrome p-450 polymorphisms and response to clopidogrel", N Engl J Med, 360, pp.354~362 (2009)
27. Lansky AJ, "Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial", Catheter Cardiovasc Interv, 72, pp.917~924 (2008)
28. Fukuuchi Y, "A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction", Cerebrovasc Dis, 25, pp.40~49 (2008)
29. Uchiyama S, "The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two Phase III, multicenter, randomized clinical trials", J Neurol, 256, pp.888~897 (2009)
30. Angiolillo DJ, "Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment", Diabetes, 54, pp.2430~2435 (2005)
31. Snoep JD, "Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systemic review and meta-analysis", Arch Intern Med, 167, pp.1593~1599 (2007)
32. Cuisset T, "Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris", Am J Cardiol, 101, pp.1700~1703 (2008)
33. Lee DH, "Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience", AJNR Am J Neuroradiol, 29, pp.1389~1394 (2008)
34. "Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical Implications", AMERICAN JOURNAL OF NEURORADIOLOGY, 31(7), pp.1206~1210 (2010), American Society of Neuroradiology

관련 논문AI추천